Disposition or Encumbrance of Collateral. The Issuer will not without the prior written consent of the Collateral Agent (A) surrender or lose possession of (other than to the Investors), sell, lease, rent or otherwise dispose of or transfer (collectively, a “Transfer”) any of its property including without limitation its intellectual property or any right or interest therein, other than: (i) Transfers of inventory in the ordinary course of business, (ii) Transfers of non-exclusive licenses and similar arrangements for the use of the property of Issuer in the ordinary course of business, or (iii) Transfers of worn-out or obsolete equipment; (B) create, incur, assume or allow any Lien with respect to any of the Collateral, outside the ordinary course of business; or (C) remove any material portion of the Collateral from its present location within the State of California.
Appears in 4 contracts
Samples: Subscription and Security Agreement (Regen Biologics Inc), Subscription and Security Agreement (Regen Biologics Inc), Subscription and Security Agreement (Regen Biologics Inc)
Disposition or Encumbrance of Collateral. The Issuer will not without the prior written consent of the Collateral Agent Investor (A) surrender or lose possession of (other than to the InvestorsInvestor), sell, lease, rent or otherwise dispose of or transfer (collectively, a “Transfer”) any of its property including without limitation its intellectual property or any right or interest therein, other than: (i) Transfers of inventory in the ordinary course of business, (ii) Transfers of non-exclusive licenses and similar arrangements for the use of the property of Issuer in the ordinary course of business, or (iii) Transfers of worn-out or obsolete equipment; (B) create, incur, assume or allow any Lien with respect to any of the Collateral, outside the ordinary course of business; or (C) remove any material portion of the Collateral from its present location within the State of California.
Appears in 1 contract
Samples: Subscription and Security Agreement (Regen Biologics Inc)